Ludger Rose
Ludger Rose publishes mostly in Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology, on topics such as Diabetes Treatment and Management, Diabetes Management and Research and Pancreatic function and diabetes.
- World rank
- #259,274 of 7,710,434 ranked researchers
- Rank in Denmark
- #1,780 of 43,819
- Works
- 64
- Citations
- 5.3k
- Citations per work
- 82.0
What does Ludger Rose research?
Ludger Rose's work is mostly in Medicine (77%), Biochemistry, Genetics and Molecular Biology (13%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences4977.1%
- Medicine4977.1%
- Life Sciences812.9%
- Everything else610.0%
- 1Endocrinology, Diabetes and Metabolism58% of their works
- 2Surgery11% of their works
- 3Molecular Biology8% of their works
- 4Cardiology and Cardiovascular Medicine7% of their works
- 5Genetics4% of their works
- 6Oncology2% of their works
Research topics
- Diabetes Treatment and Management
- Diabetes Management and Research
- Pancreatic function and diabetes
- Metabolism, Diabetes, and Cancer
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Diabetes and associated disorders
- Hormonal Regulation and Hypertension
Which keywords describe Ludger Rose's research?
The keywords of their largest research topics: Glycemic Control, Insulin Therapy, Cardiovascular Disease, Diabetes, Cardiovascular Outcomes, Type 1 Diabetes, Type 2 Diabetes and Continuous Glucose Monitoring.
- Aldosterone
- Autoimmunity
- Critical Care
- Insulin Resistance
- AMP-Activated Protein Kinase
- ß-Cell Dysfunction
- Diabetes Mellitus
- Continuous Glucose Monitoring
- Type 1 Diabetes
- Diabetes
- Insulin Therapy
- Glycemic Control
- Cardiovascular Disease
- Cardiovascular Outcomes
- Type 2 Diabetes
- Hypoglycemia
- Pancreatic Islets
- Metabolic Syndrome
- Metformin
- Obesity
- Hyperglycemia
- Genetics
- Primary Aldosteronism
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 23 words, with their numbers
- Glycemic Control873 topics
- Insulin Therapy873 topics
- Cardiovascular Disease452 topics
- Diabetes452 topics
- Cardiovascular Outcomes431 topic
- Type 1 Diabetes432 topics
- Type 2 Diabetes431 topic
- Continuous Glucose Monitoring351 topic
- Hypoglycemia351 topic
- Diabetes Mellitus242 topics
- Pancreatic Islets151 topic
- ß-Cell Dysfunction151 topic
- Metabolic Syndrome142 topics
- AMP-Activated Protein Kinase111 topic
- Metformin111 topic
- Insulin Resistance101 topic
- Obesity101 topic
- Critical Care91 topic
- Hyperglycemia91 topic
- Autoimmunity81 topic
- Genetics81 topic
- Aldosterone41 topic
- Primary Aldosteronism41 topic
Where does Ludger Rose work?
Ludger Rose's main affiliation in the publication record is Novo Nordisk (Denmark), Denmark.
How many publications and citations does Ludger Rose have?
OpenAlex counts 64 works and 5,251 citations for Ludger Rose, an h-index of 25, ranking #259,274 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Ludger Rose. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.